Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- TSSI -41.6%, STUB -18.7%, AIRO -16.9%, TE -15.2%, WYFI -13.9%, BHST -11%, CV -10.2%, DEFT -8.6%, AMAT -6.7%, ABTC -6.1%, REKR -4.9%, FFAI -4.7%, GLOB -4.6%, INBX -2.2%, SR -1.9%
Other news:
- VSTM -9.6% (prices offering consisting of common stock and warrants)
- FOSL -9.5% (files for $150 mln mixed securities shelf offering)
- GRAL -6.3% (files mixed shelf offering; also files for offering by selling security holders)
- HOOD -5.3% (October data)
- PROF -4.7% (files for $150 mln mixed securities shelf offering)
- VRT -4.4% (raises annual dividend by 67% to $0.25 per share)
- BDTX -4% (files for $500 mln mixed securities shelf offering)
- BMNR -3.9% (names new CEO and expands board with three independent directors)
- INTC -3.6% (Appaloosa exits stake)
- FENC -2.5% (prices offering 4,666,667 common shares at $7.50 per share)
- VSAT -2.4% (confirms successful launch of ViaSat-3 F2)
- ORCL -2% (Appaloosa exits stake)
- CYBR -1.8% (CYBR shareholders vote to approve deal with PANW)
- TRVI -1.3% (files mixed securities shelf offering)
- MMSI -1.2% (provides update on US reimbursement and commercial strategies for WRAPSODY)
- MRK -1.1% (Cidara Therapeutics to be acquired by Merck (MRK) for $221.50 per share in cash)
- PANW -1% (CYBR shareholders vote to approve deal with PANW)